Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03816644 · ClinicalTrials.gov registry record · NA

5-Cog Battery for Detecting Cognitive Impairment and Dementia

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
1,201
Enrollment target

NCT03816644 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 1,201 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03816644, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
1,201 participants
Enrollment target

Study Summary

Despite the availability of numerous cognitive assessment tools, cognitive impairment related to dementia is frequently under-diagnosed in primary care settings. The investigators have developed a 5-minute cognitive screen (5-Cog) coupled with a decision tree to overcome the technical, cultural and logistic barriers of current cognitive screens to improve dementia care in primary care patients with cognitive concerns.

Interventions

  • OTHER 5-Cog
  • OTHER Health Literacy & Grip Assessment

Trial Details

FieldValue
Enrollment Target 1,201 participants
Start Date 2019-05-28
Est. Completion 2023-03-15
Phase NA

Sponsor

Albert Einstein College of Medicine

175 total trials

What the Registry Record Tells You About NCT03816644

The ClinicalTrials.gov registry entry for NCT03816644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which 5-Cog is the first listed.

NCT03816644 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03816644 about?

NCT03816644 is a clinical study titled "5-Cog Battery for Detecting Cognitive Impairment and Dementia". Despite the availability of numerous cognitive assessment tools, cognitive impairment related to dementia is frequently under-diagnosed in primary care settings. The investigators have developed a 5-minute cognitive screen (5-Cog) coupled with a decision tree to overcome the technical, cultural and ...

What is the current status of trial NCT03816644?

This trial is currently completed. It is a NA study. The enrollment target is 1,201 participants. The study started on 2019-05-28. Estimated completion is 2023-03-15.

What interventions are being tested in trial NCT03816644?

The interventions under investigation include: 5-Cog (OTHER), Health Literacy & Grip Assessment (OTHER).

Who is sponsoring clinical trial NCT03816644?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.